The DOI matches its Crossref record.
Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation: A Prospective Study
Abstract
Abstract.: Neoral dosing is traditionally based on cyclosporine (CyA) trough levels (C 0). Four-h area under the curve (AUC 0-4) for Neoral in the early posttransplantation period was shown previously to have a better correlation to acute rejection (AR) and CyA nephrotoxicity (CyANT), compared with C 0. An AUC 0-4 range of 4400 to 5500 μg/h per L during the first week was associated with the lowest AR and CyANT. This article describes a prospective study to assess the feasibility, safety, and efficacy of dosing Neoral solely by AUC 0-4 monitoring, regardless of C 0, in the first 3 mo after kidney transplantation. Fifty-nine kidney transplant recipients received Neoral-based triple immunosuppression. AUC 0-4 was measured on days 3, 5, 7, 10, and 14 and weeks 3, 4, 6, and 8, then monthly. Target AUC 0-4 was 4400 to 5500 μg/h per L. Dose was adjusted by percentage difference from target AUC 0-4. Ninety-four percent of AUC were performed on the scheduled day or close to it. No patients had CyANT while AUC 0-4 was in target range. Four patients had reversible CyANT with AUC 0-4 > 5500. Only 1 of 33 patients (3%) who achieved and maintained AUC 0-4 > 4400 by day 3 posttransplantation had AR, whereas 10 of 22 (45%) of those with day 3 to 5 AUC 0-4 < 4400 had AR (P = 0.0002). In logistic regression analysis, higher early AUC 0-4 was the only significant variable associated with lower serum creatinine at 3 mo. Neoral dose monitoring by AUC 0-4 is a potentially valuable tool for optimizing Neoral immunosuppression. Attainment of a target range of 4400 to 5500 μg/h per L for AUC 0-4 early after transplantation has been demonstrated to reduce significantly the risk of AR and CyANT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Macphee, I. A. M., Fredericks, S., Tai, T., Syrris, P., Carter, N. D., Johnston, A., Goldberg, L., & Holt, D. W. (2002) · Transplantation · doi:10.1097/00007890-200212150-00002 · Cited by 315
Dunn, C. J., Wagstaff, A. J., Perry, C. M., Plosker, G. L., & Goa, K. L. (2001) · Drugs · doi:10.2165/00003495-200161130-00006 · Cited by 276
Therapeutic Monitoring of Calcineurin Inhibitors for the Nephrologist
Schiff, J., Cole, E., & Cantarovich, M. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03791106 · Cited by 257
Huang, W.-Y., Davidge, S. T., & Wu, J. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.550071 · Cited by 157
Metadata
- Authors
- MAHALATI, K., BELITSKY, P., WEST, K., KIBERD, B., FRASER, A., SKETRIS, I., MACDONALD, A. S., MCALISTER, V., & LAWEN, J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2001-04
- Volume
- 12
- Issue
- 4
- Pages
- 828-833
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2148715165
- Cited by
- 168
- References
- 0
- FWCI
- 16.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation: A Prospective Study. https://app.cochat.ai/papers/10.1681/asn.v124828
- The paper
- MAHALATI, K., BELITSKY, P., WEST, K., KIBERD, B., FRASER, A., SKETRIS, I., MACDONALD, A. S., MCALISTER, V., & LAWEN, J. (2001). Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation: A Prospective Study. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v124828
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.